Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study

Autor: Zazuli, Zulfan, Jong, Corine de de, Xu, Wei, Vijverberg, Susanne J. H., Masereeuw, Rosalinde, Patel, Devalben, Mirshams, Maryam, Khan, Khaleeq, Cheng, Dangxiao, Ordonez-Perez, Bayardo, Huang, Shao Hui, Spreafico, Anna, Hansen, Aaron R., Goldstein, David P., Almeida, John R. de de, Bratman, Scott V., Hope, Andrew, Knox, Jennifer J., Wong, Rebecca K. S., Darling, Gail E., Kitchlu, Abhijat, Haarlem, Simone W. A. van van, Meer, Femke van der, Lindert, Anne S. R. van, Heuvel, Alexandra ten ten, Brouwer, Jan, Ross, Colin J. D., Carleton, Bruce C., Egberts, Toine C. G., Herder, Gerarda J. M., Deneer, Vera H. M., Zee, Anke H. Maitland-van der, Liu, Geoffrey, Afd Pharmacology, Afd Pharmacoepi & Clinical Pharmacology, Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 1233, p 1233 (2021)
Journal of Personalized Medicine, 11(11), 1. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 11
Issue 11
Journal of Personalized Medicine, 11(11):1233. MDPI Multidisciplinary Digital Publishing Institute

This study aims to evaluate genetic risk factors for cisplatin-induced nephrotoxicity by investigating not previously studied genetic risk variants and further examining previously reported genetic associations. A genome-wide study (GWAS) was conduct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234be1d9199da0c5b37e95ea1fcdefe4
https://pubmed.ncbi.nlm.nih.gov/34834585